Humana (HUM) Stock Forecast & Price Target
0 Followers
HUM Analyst Ratings
Moderate Buy
13Buy5Hold0Sell
Based on 18 analysts giving stock ratings to Humana in the past 3 months
HUM Stock 12 Month Forecast
Average Price Target
MXN 9,119.46▲(30.88% Upside)Based on 18 Wall Street analysts offering 12 month price targets for Humana in the last 3 months. The average price target is MXN 9,119.46 with a high forecast of MXN 11,072.30 and a low forecast of MXN 7,301.03. The average price target represents a 30.88% change from the last price of MXN 6,967.90.
Past 12 Months12 Month ForecastJan2026Oct2026
HighMXN 11.07K
AverageMXN 9.12K
LowMXN 7.3K
Highest Price TargetHighestMXN 11,072.30Average Price TargetMXN 9,119.46Lowest Price TargetLowestMXN 7,301.03
Detailed List of Analyst Forecasts
Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
| Price Target | Article | |||||||
|---|---|---|---|---|---|---|---|---|
| Andrew Mok CFA | Barclays | MXN 10,812.22→MXN 10,905.11 | buy | 56.50%Upside | Reiterated | 11/09/26 | ||
| Matthew Gillmor CFA | KeyBanc | ― | hold | ― | Reiterated | 11/09/26 | ||
| Jessica Tassan | Piper Sandler | MXN 8,601.47→MXN 9,771.87 | buy | 40.24%Upside | Reiterated | 11/09/26 | ||
| Kevin Fischbeck | Bank of America Securities | MXN 9,753.29 | buy | 39.97%Upside | Reiterated | 11/06/26 | ||
| Sarah James | Cantor Fitzgerald | MXN 8,545.74→MXN 9,195.96 | buy | 31.98%Upside | Reiterated | 11/06/26 | ||
| Jason Cassorla | Guggenheim | MXN 8,750.09→MXN 9,678.98 | buy | 38.91%Upside | Reiterated | 11/06/26 | ||
| Lance Wilkes | Bernstein | MXN 7,895.52 | buy | 13.31%Upside | Reiterated | 11/04/26 | ||
| Ann Hynes | Mizuho Securities | MXN 8,694.36→MXN 9,195.96 | buy | 31.98%Upside | Reiterated | 10/13/26 | ||
| Elizabeth Anderson CFA | Evercore ISI | MXN 8,917.29 | buy | 27.98%Upside | Reiterated | 10/13/26 | ||
| Parker Snure | Raymond James | MXN 9,660.40 | buy | 38.64%Upside | Upgraded | 10/12/26 | ||
| David S Macdonald | Truist Financial | MXN 7,709.74→MXN 8,824.40 | hold | 26.64%Upside | Reiterated | 10/12/26 | ||
| A.J. Rice | UBS | MXN 7,523.97→MXN 9,195.96 | hold | 31.98%Upside | Assigned | 10/12/26 | ||
| Michael Ha | Robert W. Baird | MXN 7,245.30→MXN 11,072.30 | buy | 58.90%Upside | Upgraded | 10/09/26 | ||
| Michael Wiederhorn | Oppenheimer | MXN 7,523.97→MXN 8,824.40 | buy | 26.64%Upside | Reiterated | 10/09/26 | ||
| Ben Hendrix | RBC Capital | MXN 7,709.74 | hold | 10.65%Upside | Reiterated | 10/07/26 |
| Rating | Article | ||||
|---|---|---|---|---|---|
| Andrew Mok CFABarclays | BuyReiteratedMXN 10,812.22→MXN 10,905.11 | 11/09/26 | 56.50%Upside | ||
| Matthew Gillmor CFAKeyBanc | HoldReiterated | 11/09/26 | ― | ||
| Jessica TassanPiper Sandler | BuyReiteratedMXN 8,601.47→MXN 9,771.87 | 11/09/26 | 40.24%Upside | ||
| Kevin FischbeckBank of America Securities | BuyReiteratedMXN 9,753.29 | 11/06/26 | 39.97%Upside | ||
| Sarah JamesCantor Fitzgerald | BuyReiteratedMXN 8,545.74→MXN 9,195.96 | 11/06/26 | 31.98%Upside | ||
| Jason CassorlaGuggenheim | BuyReiteratedMXN 8,750.09→MXN 9,678.98 | 11/06/26 | 38.91%Upside | ||
| Lance WilkesBernstein | BuyReiteratedMXN 7,895.52 | 11/04/26 | 13.31%Upside | ||
| Ann HynesMizuho Securities | BuyReiteratedMXN 8,694.36→MXN 9,195.96 | 10/13/26 | 31.98%Upside | ||
| Elizabeth Anderson CFAEvercore ISI | BuyReiteratedMXN 8,917.29 | 10/13/26 | 27.98%Upside | ||
| Parker SnureRaymond James | BuyUpgradedMXN 9,660.40 | 10/12/26 | 38.64%Upside | ||
| David S MacdonaldTruist Financial | HoldReiteratedMXN 7,709.74→MXN 8,824.40 | 10/12/26 | 26.64%Upside | ||
| A.J. RiceUBS | HoldAssignedMXN 7,523.97→MXN 9,195.96 | 10/12/26 | 31.98%Upside | ||
| Michael HaRobert W. Baird | BuyUpgradedMXN 7,245.30→MXN 11,072.30 | 10/09/26 | 58.90%Upside | ||
| Michael WiederhornOppenheimer | BuyReiteratedMXN 7,523.97→MXN 8,824.40 | 10/09/26 | 26.64%Upside | ||
| Ben HendrixRBC Capital | HoldReiteratedMXN 7,709.74 | 10/07/26 | 10.65%Upside |
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Best Analysts Covering Humana
3 Months
Success Rate14/18 ratings generated profit
78%
Average Return
+19.23%
Copying Lance Wilkes's trades and holding each position for 3 Months would result in 77.78% of your transactions generating a profit, with an average return of +19.23% per trade.
1 Year
Success Rate14/18 ratings generated profit
78%
Average Return
+35.12%
Copying Lance Wilkes's trades and holding each position for 1 Year would result in 77.78% of your transactions generating a profit, with an average return of +35.12% per trade.
2 Years
Success Rate18/18 ratings generated profit
100%
Average Return
+59.42%
Copying Lance Wilkes's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +59.42% per trade.
HUM Analyst Recommendation Trends
| Rating | Jun 26 | Jul 26 | Aug 26 | Sep 26 | Oct 26 |
|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 0 | 0 |
| Buy | 17 | 16 | 19 | 19 | 22 |
| Hold | 23 | 20 | 17 | 7 | 6 |
| Sell | 4 | 3 | 2 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 45 | 40 | 39 | 26 | 28 |
In the current month, HUM has received 22 Buy Ratings, 6 Hold Ratings, and 0 Sell Ratings. HUM average Analyst price target in the past 3 months is 9,119.46.
HUM Financial Forecast
HighMXN -123.11
ConsensusMXN -142.75
LowMXN -157.46
HUM Earnings Forecast
Next quarter’s earnings estimate for HUM is -MXN 142.75 with a range of -MXN 157.46 to -MXN 123.11. The previous quarter’s EPS was -MXN 13.04. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
HighMXN 778B
ConsensusMXN 768B
LowMXN 760B
HUM Sales Forecast
Next quarter’s sales forecast for HUM is MXN 768.44B with a range of MXN 760.50B to MXN 777.89B. The previous quarter’s sales results were MXN 766.53B. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.
HUM Stock Forecast FAQ
What is MX:HUM’s average 12-month price target, according to analysts?
Based on analyst ratings, Humana’s 12-month average price target is Mex$9,119.46.
What is MX:HUM’s upside potential, based on the analysts’ average price target?
Humana has 30.88% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Humana a Buy, Sell or Hold?
Humana has a consensus rating of Moderate Buy, which is based on 13 buy ratings, 5 hold ratings and 0 sell ratings.
What is Humana’s share price target?
The average share price target for Humana is Mex$9,119.46. This is based on 18 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is Mex$11,072.30, and the lowest forecast is Mex$7,301.03. The average share price target represents a 30.88% increase from the current price of Mex$6,967.9.
What do analysts say about Humana?
Humana’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 18 Wall Street analysts.
How can I buy shares of Humana?
To buy shares of MX:HUM, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
